- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Serevent was developed by GlaxoSmithKline for the treatment of asthma. A study found that the drug can trigger fatal heart attacks in some patients. Since then, the FDA has forced Glaxo to place a black box warning on Serevent and its sister drug Advair, disclosing the significant risk of death on the packaging and in advertisements. Serevent is a daily spray to open the bronchial airways, allowing asthma patients to breathe more easily. Serevent has been shown to be a very popular asthma medication and is widely used throughout the world. The risks associated with Serevent can been shown by clinical studies. One such study contends that three times the number of asthmatics using Serevent have died of asthma than asthma patients who used alternate medications.
If you or a loved one is taking Serevent, you should consult a physician with any
concerns you may have regarding side effects and complications immediately. Patients
who believe they are suffering from side effects of Serevent or Advair should contact
an attorney who has experience in this type of drug product liability law. Patients
injured by their use of Serevent could be entitled to financial awards for economic
and general damages.


